StockData
Liquidia Corp logo

Liquidia Corp (LQDA) stock

LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3075% above fair value
$56.73+0.36 (+0.64%)

Close on Nov 17, 2026Market cap $5.08BP/E 40.8Yield –

Liquidia EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Liquidia's EPS for the twelve months ending Jun 30, 2026 was $1.39. For fiscal 2025 it was -$0.80. The highest annual figure on record is -$0.67 in fiscal 2022.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$0.80–
FY2024Dec 31, 2024-$1.63–
FY2023Dec 31, 2023-$1.21–
FY2022Dec 31, 2022-$0.67–
FY2021Dec 31, 2021-$0.70–
FY2020Dec 31, 2020-$1.76–
FY2019Dec 31, 2019-$2.57–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0.74–
Q1 FY2026Mar 31, 2026$0.52–
Q4 FY2025Dec 31, 2025$0.17–
Q3 FY2025Sep 30, 2025-$0.04–
Q2 FY2025Jun 30, 2025-$0.49–
Q1 FY2025Mar 31, 2025-$0.45–
Q4 FY2024Dec 31, 2024-$0.45–
Q3 FY2024Sep 30, 2024-$0.40–
Q2 FY2024Jun 30, 2024-$0.38–
Q1 FY2024Mar 31, 2024-$0.40–
Q4 FY2023Dec 31, 2023-$0.42–
Q3 FY2023Sep 30, 2023-$0.24–
Q2 FY2023Jun 30, 2023-$0.36–
Q1 FY2023Mar 31, 2023-$0.18–
Q4 FY2022Dec 31, 2022-$0.10–
Q3 FY2022Sep 30, 2022-$0.14–
Q2 FY2022Jun 30, 2022-$0.15–
Q1 FY2022Mar 31, 2022-$0.30–
Q4 FY2021Dec 31, 2021-$0.22–
Q3 FY2021Sep 30, 2021-$0.14–
Q2 FY2021Jun 30, 2021-$0.13–
Q1 FY2021Mar 31, 2021-$0.21–
Q4 FY2020Dec 31, 2020-$0.39–
Q3 FY2020Sep 30, 2020-$0.40–
Q2 FY2020Jun 30, 2020-$0.49–
Q1 FY2020Mar 31, 2020-$0.52–

More Liquidia figures

See a number that looks wrong?